TH96250B - Chemical compounds for use in the manufacture of drugs to treat and prevent metabolic disorders. - Google Patents

Chemical compounds for use in the manufacture of drugs to treat and prevent metabolic disorders.

Info

Publication number
TH96250B
TH96250B TH802001045F TH0802001045F TH96250B TH 96250 B TH96250 B TH 96250B TH 802001045 F TH802001045 F TH 802001045F TH 0802001045 F TH0802001045 F TH 0802001045F TH 96250 B TH96250 B TH 96250B
Authority
TH
Thailand
Prior art keywords
metabolic disorders
drugs
treat
manufacture
chemical compounds
Prior art date
Application number
TH802001045F
Other languages
Thai (th)
Other versions
TH145108A (en
TH36033S1 (en
TH96250S (en
Inventor
คอลลินส์
แอนน์ เซล นางซาร่า
Original Assignee
แกลกโซสมิธไคลน์ แอลแอลซี
แอลอาร์ซี โปรดัคท์ส ลิมิเต็ด
Filing date
Publication date
Publication of TH96250S publication Critical patent/TH96250S/en
Application filed by แกลกโซสมิธไคลน์ แอลแอลซี, แอลอาร์ซี โปรดัคท์ส ลิมิเต็ด filed Critical แกลกโซสมิธไคลน์ แอลแอลซี
Publication of TH36033S1 publication Critical patent/TH36033S1/en
Publication of TH145108A publication Critical patent/TH145108A/en
Publication of TH96250B publication Critical patent/TH96250B/en

Links

Abstract

DC60 (21/01/56) ได้เปิดเผย สารประกอบของสูตร I และ วิธีสำหรับรักษา ความผิดปกติทางเมทาโบลิซึม (สูตรเคมี) l ได้เปิดเผยสารประกอบของสูตร I และ วิธีสำหรับรักษา ความผิดปกติทางเมทาโบลิซึม (สูตรเคมี) lDC60 (21/01/56) has revealed the compound of formula I and the method for treating metabolic disorders (chemical formula) l has revealed the compound of formula I and the method for treating metabolic disorders (chemical formula) l

TH802001045F 2011-04-27 Chemical compounds for use in the manufacture of drugs to treat and prevent metabolic disorders. TH96250B (en)

Publications (4)

Publication Number Publication Date
TH96250S TH96250S (en) 2009-06-30
TH36033S1 TH36033S1 (en) 2013-07-02
TH145108A TH145108A (en) 2016-02-05
TH96250B true TH96250B (en) 2023-10-16

Family

ID=

Similar Documents

Publication Publication Date Title
JO3131B1 (en) Chemical compounds
PH12019501321A1 (en) Methods of treating or preventing cholesterol related disorders
MX344521B (en) Heterocycle amines and uses thereof.
LT2726511T (en) COMPOSITIONS, USES AND METHODS FOR THE TREATMENT OF METABOLIC DISORDERS AND DISEASES
EA201391615A1 (en) DATED POTENTIATORS CFTR
MX2013008192A (en) Bace-2 inhibitors for the treatment of metabolic disorders.
EP2558115A4 (en) METHODS OF TREATING METABOLIC DISORDERS USING FGF
BR112015029970A2 (en) kinase inhibitors
EA201491028A1 (en) METHOD OF OBTAINING SUBSTITUTED 5-FLUOR-1H-PYRAZOLOPIRIDINES
IL228030B (en) Compounds for the treatment of gout and gout-related metabolic disorders
MY157429A (en) Trpm8 antagonists and their use in treatments
CA2929436C (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
SI2771329T1 (en) Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
BR112015029462A2 (en) KINASE INHIBITORS
PL2718434T3 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOUS DISEASE
IT1406864B1 (en) COMPOSITION FOR ACNE TREATMENT
BR112013015048A2 (en) composition for the treatment of metabolic disorders
NZ707773A (en) Methods of treating liver diseases
ITRM20120405A1 (en) COMPOUNDS FOR USE IN THE TREATMENT OF DISORDERS THAT ARE AMELIORATED BY INHIBITION OF HDAC
UA113859C2 (en) SPIROTIENOPIRAN-PIPERIDINE DERIVATIVES AS AN ORL-1 RECEIVER ANTAGONS FOR THEIR APPLICATION IN THE TREATMENT OF ALCOHOLIC DEPENDENCE AND ABUSE
PH12014500577A1 (en) Sulfonic acid salts of heterocyclylamide-substituted imidazoles
HRP20180011T1 (en) COMPOUNDS FOR USE IN THE TREATMENT OF FILARIASES
TH145108A (en) Chemical compounds used in the manufacture of drugs to treat and prevent metabolic disorders.
EA201491769A1 (en) PHARMACEUTICAL COMPOSITION WITH FIXED DOSE CONTAINING MOMETHASON AND AZELASTIN
GB201106142D0 (en) Compounds for the treatment of metabolic disorders